2941: Antibiotics
COMESA
294110
Penicillins & their derivatives with a penicillanic acid structure; salts thereof
294120
Streptomycins & their derivatives; salts thereof
294130
Tetracyclines & their derivatives; salts thereof
294140
Chloramphenicol & its derivatives; salts thereof
294150
Erythromycin & its derivatives; salts thereof
294190
Antibiotics & their derivatives (excl. of 2941.10-2941.50); salts thereof
Goods are considered originating if they have been produced in the member States wholly or partially from materials imported from outside the member States or of undetermined origin provided that:
- The c.i.f. value of those materials does not exceed 60% of the total cost of the materials used in the production of the goods;
- The value added resulting from the process of production accounts for at least 35% of the ex-factory cost of the goods;
- Manufacture from materials classified in a heading other than that of the product
SADC
294110
Penicillins & their derivatives with a penicillanic acid structure; salts thereof
294120
Streptomycins & their derivatives; salts thereof
294130
Tetracyclines & their derivatives; salts thereof
294140
Chloramphenicol & its derivatives; salts thereof
294150
Erythromycin & its derivatives; salts thereof
294190
Antibiotics & their derivatives (excl. of 2941.10-2941.50); salts thereof
- Manufacture in which all the materials used are classified within a heading other than that of the product
EAC
294110
Penicillins & their derivatives with a penicillanic acid structure; salts thereof
294120
Streptomycins & their derivatives; salts thereof
294130
Tetracyclines & their derivatives; salts thereof
294140
Chloramphenicol & its derivatives; salts thereof
294150
Erythromycin & its derivatives; salts thereof
294190
Antibiotics & their derivatives (excl. of 2941.10-2941.50); salts thereof
Goods are considered originating if they have been produced in the member States wholly or partially from materials imported from outside the member States or of undetermined origin provided that:
- The c.i.f. value of those materials does not exceed 60% of the total cost of the materials used in the production of the goods;
- The value added resulting from the process of production accounts for at least 35% of the ex-factory cost of the goods;
- Manufacture from materials classified within a heading other than that of the product - Manufacture from any other heading is recognized as a substantial process.
EU GSP
294110
Penicillins & their derivatives with a penicillanic acid structure; salts thereof
294120
Streptomycins & their derivatives; salts thereof
294130
Tetracyclines & their derivatives; salts thereof
294140
Chloramphenicol & its derivatives; salts thereof
294150
Erythromycin & its derivatives; salts thereof
294190
Antibiotics & their derivatives (excl. of 2941.10-2941.50); salts thereof
- Manufacture from materials of any heading, except that of the product. However, materials of the same heading as the product may be used, provided that their total value does not exceed 20% of the ex-works price of the product
- Manufacture in which the value of all the materials used does not exceed 40% of the ex-works price of the product